SCHEMBL5653667

SCHEMBL5653667

Cc1ccnc(-c2ccc(S(=O)(=O)N3CCN(C(=O)c4ccccc4)CC3C)s2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GFER P55789 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAP3K12 Q12852 1/20 0.43
SLC6A7 Q99884 1/20 0.42
ABL1 P00519 4/20 0.42
BCR P11274 4/20 0.42
MMP8 P22894 2/20 0.42
SMO Q99835 2/20 0.42
MMP3 P08254 2/20 0.42
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GHSR Q92847 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP7 P09237 1/20 0.40
GSK3B P49841 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14366931 0.89 MMP8 (0.52) ALDH1A1SLC6A7MMP8SMOMMP3
SCHEMBL5653521 0.88 SLC6A7 (0.47) ALDH1A1SLC6A7MMP8SMOMMP3
SCHEMBL5652959 0.86 GSK3B (0.51) GFERALDH1A1SLC6A7MMP8SMO
SCHEMBL5656800 0.85 SMO (0.44) ALDH1A1SLC6A7MMP8SMOMMP3
SCHEMBL5652538 0.85 SMO (0.45) HTTL3MBTL1SLC6A7SMOMMP3
SCHEMBL5654070 0.85 GRM5 (0.45) GRM5HTTL3MBTL1ALDH1A1MMP8
SCHEMBL5654387 0.85 SMO (0.41) HTTL3MBTL1ALDH1A1SLC6A7MMP8
SCHEMBL5652388 0.85 SMO (0.50) HTTL3MBTL1GFERSLC6A7SMO
SCHEMBL5652861 0.84 SMO (0.46) SLC6A7SMOMMP3GHSRMMP1
SCHEMBL5655469 0.84 CYP2C19 (0.42) SLC6A7SMOCYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259879-A1 Piperazine and piperidine biaryl derivatives TRIMERIS, INC. 2007-11-08 US disclosed
US-20070259879-A1 Piperazine and piperidine biaryl derivatives TRIMERIS, INC. 2007-11-08 US disclosed
US-20070259879-A1 Piperazine and piperidine biaryl derivatives TRIMERIS, INC. 2007-11-08 US disclosed
WO-2007103456-A2 PIPERAZINE AND PIPERIDINE BIARYL DERIVATIVES TRIMERIS, INC. (US) 2007-09-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259879-A1 Piperazine and piperidine biaryl derivatives CYP3A5, CYP3A43, CCR5 GRM5 749/4885HTT 3642/4885L3MBTL1 4497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.